From 4 aspects as diabetes, ischemic heart and brain diseases, strokes and tumors, this paper reviews the research advances of drug development based on interference in glycometabolism.
本文从糖尿病、缺血性心脑损伤、中风、肿瘤等4个方面，综述了近年来以糖代谢干预为基础的新药研究进展。
From 4 aspects as diabetes, ischemic heart and brain diseases, strokes and tumors, this paper reviews the research advances of drug development based on interference in glycometabolism.
本文从糖尿病、缺血性心脑损伤、中风、肿瘤等4个方面，综述了近年来以糖代谢干预为基础的新药研究进展。
应用推荐